Trial intelligence / Profile preview

Effect of polyethylene glycol in the treatment of hepatic encephalopathy

IRCT2015083117719N2Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Sep 2015
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of macrogol in hepatic encephalopathy (HE), sponsored by Tehran University of Medical Sciences. Started Sep 2015; status: completed.

02

Drugs

macrogol
03

Conditions

hepatic encephalopathy (HE)

Beyond the preview

Go deeper on IRCT2015083117719N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015083117719N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call